These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Costameric distribution of beta-dystroglycan (43 kDa dystrophin-associated glycoprotein) in normal and dystrophin-deficient human skeletal muscle. Herrmann R; Anderson LV; Voit T Biochem Soc Trans; 1996 May; 24(2):501-6. PubMed ID: 8736792 [No Abstract] [Full Text] [Related]
10. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle. Martin PT Glycobiology; 2003 Aug; 13(8):55R-66R. PubMed ID: 12736199 [TBL] [Abstract][Full Text] [Related]
11. Artificial sweeteners--enhancing glycosylation to treat muscular dystrophies. Rando TA N Engl J Med; 2004 Sep; 351(12):1254-6. PubMed ID: 15371584 [No Abstract] [Full Text] [Related]
13. Cardiomyopathic features associated with muscular dystrophy are independent of dystrophin absence in cardiovasculature. Hainsey TA; Senapati S; Kuhn DE; Rafael JA Neuromuscul Disord; 2003 May; 13(4):294-302. PubMed ID: 12868498 [TBL] [Abstract][Full Text] [Related]
14. Dystrophin-associated glycoproteins: their possible roles in the pathogenesis of Duchenne muscular dystrophy. Ervasti JM; Campbell KP Mol Cell Biol Hum Dis Ser; 1993; 3():139-66. PubMed ID: 8111538 [TBL] [Abstract][Full Text] [Related]
15. Dystrophin: the long and short of it. Worton RG J Clin Invest; 1994 Jan; 93(1):4. PubMed ID: 8282811 [No Abstract] [Full Text] [Related]
16. [Animal models for muscle research and muscle diseases]. Nabeshima Y Tanpakushitsu Kakusan Koso; 1995 Oct; 40(14):2197-203. PubMed ID: 8532876 [No Abstract] [Full Text] [Related]